/Companies

メタジェンセラピューティクス

Tsuruoka, JP · 7 known investors

Find your way into メタジェンセラピューティクス

Sign up to see every warm intro you have to メタジェンセラピューティクス

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the メタジェンセラピューティクス team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Metagen Therapeutics (メタジェンセラピューティクス) is a biotech venture developing fecal microbiota transplantation (FMT) therapies and medical services based on gut microbiome research, including an FMT drug candidate (MGT-006) for ulcerative colitis. Based in Japan, it operates across drug discovery and medical services and runs a stool donation platform to source raw material.

Founders & leadership

TN
Taku Nakahara代表取締役社長CEO (President & CEO)
JT
Jun TerauchiCSO

Investors · 7

Frequently asked questions

What does メタジェンセラピューティクス do?
Metagen Therapeutics (メタジェンセラピューティクス) is a biotech venture developing fecal microbiota transplantation (FMT) therapies and medical services based on gut microbiome research, including an FMT drug candidate (MGT-006) for ulcerative colitis. Based in Japan, it operates across drug discovery and medical services and runs a stool donation platform to source raw material.
Who founded メタジェンセラピューティクス?
メタジェンセラピューティクス was founded by Taku Nakahara.
Who are メタジェンセラピューティクス's investors?
メタジェンセラピューティクス's investors include 15th Rock, Dentsu Ventures, Fast Track Initiative, Global Brain, Mirai Creation Fund, MIRAI SOUZOU, Nippon Venture Capital.
Where is メタジェンセラピューティクス headquartered?
メタジェンセラピューティクス is headquartered in Tsuruoka, JP.